Synthesis of potent non-imidazole histamine H3-receptor antagonists

Archiv der Pharmazie

Volumn 331, Issue 12, 1998, Pages 395-404

  Ganellin, C Robin ^a   Leurquin, Fabien ^a   Piripitsi, Antonia ^a   Arrang, Jean Michel ^b   Garbarg, Monique ^b   Ligneau, Xavier ^c   Schunack, Walter ^d   Schwartz, Jean Charles ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRE PAUL BROCA   (France)

^c Laboratoire Bioprojet   (France)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Brain penetration; H3 receptors; Histamine antagonists

Indexed keywords

HISTAMINE H3 RECEPTOR ANTAGONIST; N ETHYL N (4 PHENYLBUTYL)AMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; AMINES; ANIMALS; BRAIN; BUTYLAMINES; HISTAMINE; HISTAMINE ANTAGONISTS; METHYLHISTAMINES; MOLECULAR STRUCTURE; PYRROLIDINES; RATS; RECEPTORS, HISTAMINE H3; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES;

EID: 0032412527     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7     Document Type: Article

References (18)

1. J.-M. Arrang, M. Garbarg, J.-C. Schwartz, Neuroscience 1987, 23, 149-157.
2. J.-M. Arrang, M. Garbarg, J.-C. Schwartz, Nature (London) 1983, 302, 832-837.
3. E. Schlicker, B. Malinowska, , M. Kathmann, M. Göthert, Fundam. Clin. Pharmacol. 1994, 8, 128-137.
4. R. Leurs, P. Blandina, C. Tedford, H. Timmerman, Trends Pharmacol. Sci. 1998, 19, 177-183.
5. H. Stark, E. Schlicker, W. Schunack, Drugs Future 1996, 21, 507-520.
6. J.-M. Arrang, M. Garbarg, J.-C. Lancelot, J.-M. Lecomte, H. Pollard, M. Robba, W. Schunack, J.-C. Schwartz, Nature (London) 1987, 327, 117-123.
7. E. Sakurai, E. Gunji, Y. Iizuka, N. Hikichi, K. Maeyama, T. Watanabe, J. Pharm. Pharmacol. 1994, 46, 209-212.
8. F. Bordi, S. Rivara, A. Caretta, V. Ballabeni, E. Barocelli, P.V Plazzi, Farmaco, 1997, 52, 457-462.
9. W.D. Stein, The Movement of Molecules Across Cell Membranes; Academic Press: New York, 1967, pp 65-91.
10. H.S. Chadha, M.H. Abraham, R.C. Mitchell, Bioorg. Med. Chem. Lett. 1994, 4, 2511-2516.
11. R.C. Young, R.C. Mitchell, T. H. Brown, C.R. Ganellin, R. Griffiths, M. Jones, K.K. Rana, D. Saunders, I.R. Smith, N.E. Sore, T.J. Wilks. J. Med. Chem. 1988, 31, 656-671.
12. J.-M. Arrang, M. Garbarg, T.T. Quach, M.D.T. Tuong, E. Yeramian, J.-C. Schwartz, Eur. J. Pharmacol. 1985, 111, 73-84.
13. J.-M. Arrang, N. Defontaine, J.-C. Schwartz, Eur. J. Pharmacol. 1988, 157, 31-35.
14. J.-C. Schwartz, J.-M. Arrang, M. Garbarg, H. Pollard, Agents Actions 1990, 30, 13-23.
15. C.R. Ganellin, D. Jayes, Y.S. Khalaf, W. Tertiuk, J.-M. Arrang, N. Defontaine, J.-C. Schwartz, Coll. Czech. Chem. Commun. 1991, 56, 2448-2455.
16. M. Kathmann, E. Schlicker, M. Göthert, Psychopharmacol. 1994, 116, 464-468.
17. K. Kiec-Kononowicz, X. Ligneau, H. Stark, J.-C. Schwartz, W. Schunack, Arch. Pharm. Pharm. Med. Chem. 1995, 328, 445-150.
18. K. Kiec-Kononowicz, X. Ligneau, J.-C. Schwartz, W. Schunack, Arch. Pharm. Pharm. Med. Chem. 1995, 328, 469-472.